Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 15 2020 - 4:05PM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for cancer and autoimmune/inflammatory
diseases, today announced the company will present at the
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on
Tuesday, September 22, 2020, at 3:20 p.m. ET/12:20 p.m. PT.
A live webcast of the presentation will be available online in
the investor relations section of the company’s website at
https://ir.alpineimmunesciences.com/events. A replay of the
presentation will be available on the company website for 90 days
following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is committed to leading a new wave
of immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is creating multifunctional immunotherapies
via unique protein engineering technologies to improve patients’
lives. For more information, visit www.alpineimmunesciences.com.
Follow @AlpineImmuneSci on Twitter and LinkedIn.
“Secreted Immunomodulatory Proteins,” “SIP,” “Transmembrane
Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and
the Alpine logo are registered trademarks or trademarks of Alpine
Immune Sciences, Inc. in various jurisdictions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200915006148/en/
Paul Rickey Chief Financial Officer Alpine Immune Sciences, Inc.
206-788-4545 ir@alpineimmunesciences.com
Laurence Watts Managing Director Gilmartin Group, LLC.
619-916-7620 laurence@gilmartinir.com
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Apr 2023 to Apr 2024